February 18, 2020, the Board of Directors of NeuroOne Medical Technologies Corporation voted to increase the size of the Board to four members and voted to appoint Edward Andrle to the Board to fill the vacancy created by the increase in Board size, effective February 18, 2020. Mr. Andrle will also serve on the Audit Committee of the Board. Mr. Andrle mostly recently served as the General Manager of Neuromodulation of LivaNova PLC, a publicly-traded medical device company, from January 2018 to January 2020, and as Senior Vice President of Strategy & Business Development of LivaNova from September 2015 to January 2018.